Effects of Chinese herbal medicine in patients with benign prostatic hyperplasia: A nationwide cohort study in Taiwan

被引:1
|
作者
Ou, Shi-Chen [1 ,2 ]
Huang, Sheng-Teng [1 ,3 ,4 ,5 ]
Lin, Mei-Chen [6 ]
Chen, Wen-Chi [7 ,8 ]
Huang, Chi-Ping [7 ,9 ]
Lin, Hung-Jen [1 ,2 ]
机构
[1] China Med Univ Hosp, Dept Chinese Med, 2 Yude Rd, Taichung 404, Taiwan
[2] China Med Univ, Sch Post Baccalaureate Chinese Med, Taichung, Taiwan
[3] China Med Univ, Sch Chinese Med, Taichung, Taiwan
[4] China Med Univ Hosp, Canc Res Ctr Tradit Chinese Med, Dept Med Res, Taichung, Taiwan
[5] China Med Univ, Nan Hosp, Tainan, Taiwan
[6] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan
[7] China Med Univ Hosp, Dept Urol, Taichung, Taiwan
[8] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan
[9] China Med Univ, Sch Med, Taichung, Taiwan
关键词
benign prostatic hyperplasia; Chinese herbal medicine; Ji-Sheng-Shen-Qi-Wan; National Health Insurance Research Database; retrospective cohort study; URINARY-TRACT SYMPTOMS; DOUBLE-BLIND; MEN; DUTASTERIDE; FINASTERIDE; GUIDELINES;
D O I
10.1111/iju.14853
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives Benign prostatic hyperplasia affects elderly males, with progression presenting the risk of urinary complications and eventual surgical intervention. We aimed to evaluate the effects of Chinese herbal medicine in patients with benign prostatic hyperplasia. Methods This retrospective cohort study analyzed claims data in Taiwan's National Health Insurance Research Database from 2001 to 2013. A total of 4142 patients newly diagnosed as benign prostatic hyperplasia were enrolled and divided into cohorts of Chinese herbal medicine users and nonusers by performing 1:1 propensity score matching. The risk of benign prostatic hyperplasia-related complications was assessed by the Cox proportional hazard model. The cumulative incidence of benign prostatic hyperplasia-related surgeries was assessed by Kaplan-Meier method. Results During the study period, the risk of benign prostatic hyperplasia-related complications was lower in the Chinese herbal medicine cohort than non-Chinese herbal medicine cohort with an adjusted hazard ratio of 0.82 (95% confidence interval 0.73-0.92) after controlling for multiple variables. Subgroup analysis revealed that Chinese herbal medicine users had a significantly lower risk of urinary tract infection (adjusted hazard ratio 0.67, 95% confidence interval 0.50-0.89) and urinary retention (adjusted hazard ratio 0.83, 95% confidence interval 0.72-0.97). In addition, Chinese herbal medicine users also had a lower incidence rate of benign prostatic hyperplasia-related surgery (32.14 vs 40.20, adjusted hazard ratio 0.74, 95% confidence interval 0.61-0.89) and a longer surgery-free interval than non-Chinese herbal medicine users (3.98 vs 3.00 mean person-year, P < 0.001). Data revealed Salviae miltiorrhizae and Ji-Sheng-Shen-Qi-Wan as the most commonly prescribed Chinese herbal medicine by traditional Chinese medicine practitioners. Conclusions Our study demonstrated that Chinese herbal medicine might have effects in the benign prostatic hyperplasia-related complications and surgeries in patients with benign prostatic hyperplasia.
引用
收藏
页码:623 / 630
页数:8
相关论文
共 50 条
  • [31] Personalized medicine for men with benign prostatic hyperplasia
    Nature Clinical Practice Urology, 2008, 5 (5): : 236 - 237
  • [32] The contribution of benign prostatic hyperplasia and subsequent risk of urinary bladder cancer: An Asian population cohort study in Taiwan
    Liao, C. -H.
    Fang, C. -W.
    Muo, C. -H.
    Wu, S. -C.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 60 - 60
  • [33] Efficacy evaluation of Chinese herbal medicine, VGH-BPH1, for patients with benign prostatic hyperplasia: A randomized, double-blind, placebo-controlled, and crossover study
    Diem Ngoc Hong Tran
    Yeh, Hsin-Fu
    Huang, William J.
    Wu, Pei-Wen
    Liao, Ying-Ju
    Hwang, Shinn-Jang
    Kung, Yen-Ying
    Yang, Jen-Lin
    Wu, Ta-Peng
    Hsu, Chung-Hua
    Chen, Fang-Pey
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2022, 85 (05) : 639 - 646
  • [34] Variation of prostatic morphology in Chinese benign prostatic hyperplasia patients of different age decades
    Qian, Subo
    Sheng, Xujun
    Xu, Ding
    Shen, Haibo
    Qi, Jun
    Wu, Yu
    AGING MALE, 2020, 23 (05): : 457 - 463
  • [35] Telephone medicine: A novel approach to managing patients with benign prostatic hyperplasia
    Baum, N
    INFECTIONS IN UROLOGY, 1999, 12 (05): : 141 - 145
  • [36] Chinese Herbal Medicine for Constipation in Taiwan
    Lu, Ching-Liang
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2010, 73 (10) : 511 - 512
  • [37] Association between use of Chinese herbal medicine and depression risk in patients with rheumatoid arthritis: A nationwide retrospective cohort study
    Li, Hsin-Hua
    Livneh, Hanoch
    Yeh, Chia-Chou
    Guo, How-Ran
    Lai, Ning-Sheng
    Lu, Ming-Chi
    Tsai, Tzung-Yi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (06) : 986 - 994
  • [38] Chinese Urologists' Views of Practice Patterns in the Diagnosis and Treatment of Benign Prostatic Hyperplasia: A Nationwide Survey
    Wu, Nan
    Sun, Jian
    Yu, Pulin
    Sun, Zhenqiu
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2012, 16 (04) : 191 - 195
  • [39] Radiological Findings of Prostatic Arterial Anatomy for Prostatic Arterial Embolization: Preliminary Study in 55 Chinese Patients with Benign Prostatic Hyperplasia
    Zhang, Guodong
    Wang, Maoqiang
    Duan, Feng
    Yuan, Kai
    Li, Kai
    Yan, Jieyu
    Chang, Zhongfei
    Wang, Yan
    PLOS ONE, 2015, 10 (07):
  • [40] Chinese Herbal Medicine Improves the Long-Term Survival Rate of Patients With Chronic Kidney Disease in Taiwan: A Nationwide Retrospective Population-Based Cohort Study
    Huang, Kuo-Chin
    Su, Yuan-Chih
    Sun, Mao-Feng
    Huang, Sheng-Teng
    FRONTIERS IN PHARMACOLOGY, 2018, 9